Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
15.68x2.89x-4.64x2.54x8.03x7.57x-.--% 1.93TCr
19.2x2.25x-3.59x4.41x13.12x13.68x0.52% 7.74TCr
29.09x4.09x2.55x5.8x16.75x21.06x0.55% 5.97TCr
39.01x7.97x0.72x13.14x24.06x28.61x-.--% 5.04TCr
35.98x2.48x-0.65x3.6x10.41x11.83x2.95% 4.79TCr
15.18x1.31x0.43x2.87x8.57x9.36x-.--% 2.65TCr
-7.51x3.39x17.92x8.44x-6.46x-6.03x-.--% 2.15TCr
24.4x3.42x0.02x4.94x13.47x17.97x-.--% 1.55TCr
-39.86x-6.4x0.82x17.96x-50.08x-59.08x-.--% 1.51TCr
74.84x29.64x0.85x38.5x52.33x53.32x0.09% 1.36TCr
12.86x - 0.09x3.06x13.33x24.36x-.--% 1.06TCr
-210x59.4x2.76x9.4x218.15x-216.23x-.--% 942.14Cr
34.4x - 2.43x - - - -.--% 790.47Cr
85.85x6.07x-1.1x - - - - 809.35Cr
-217.92x - 0.67x - - - -.--% 730.65Cr
11.84x1.07x0.34x1.83x7.3x9.66x2.04% 695.43Cr
35.27x - 0.44x9.13x27.34x33.66x0.27% 575.8Cr
-12.05x1.2x0.05x2.31x-22.21x-22.64x0.46% 553.32Cr
20.32x1.08x1.22x - - - 1.58% 547.18Cr
Average -1.76x 7.99x 1.12x 8.53x 22.27x -4.86x 0.47% 2.18TCr
Weighted average by Cap. 14.76x 5.47x 0.64x 7.52x 16.66x 7.94x 0.6%
Biopharmaceuticals